Is Visceral Fat the Biggest Risk Factor?

What Is Visceral Fat and Why Does It Matter?

Visceral fat is fat stored deep in the abdominal cavity, surrounding organs such as the liver, pancreas, and intestines. Unlike subcutaneous fat — the fat visible just beneath the skin — visceral fat is metabolically active in ways that directly affect long-term health. It releases pro-inflammatory cytokines, disrupts insulin signalling, and contributes to a chronic low-grade inflammatory state that accelerates biological aging.

This matters for longevity because visceral fat doesn’t just reflect excess calorie storage. It actively participates in metabolic dysfunction. As a result, someone can carry significant visceral fat at a seemingly normal body weight — and face elevated health risks without knowing it.

In contrast, subcutaneous fat, while not entirely benign, is considerably less harmful and does not carry the same metabolic consequences. The distinction is clinically important and frequently overlooked.

Why Visceral Fat Is a Major Longevity Risk Factor

Visceral fat sits near the portal vein, which carries blood directly to the liver. This proximity means that free fatty acids and inflammatory molecules released by visceral fat reach the liver in high concentrations — contributing to insulin resistance, elevated triglycerides, and non-alcoholic fatty liver disease.

Research consistently links excess visceral fat to:

• Insulin resistance and type 2 diabetes
• Elevated cardiovascular risk, including high blood pressure, raised ApoB, and arterial inflammation
• Systemic inflammation, reflected in elevated CRP and other inflammatory markers
• Increased risk of certain cancers, including colorectal and breast cancer
• Cognitive decline and dementia risk, likely via vascular and inflammatory pathways

Importantly, visceral fat is strongly associated with insulin resistance — which many researchers consider a root driver of metabolic disease rather than simply a downstream consequence of it. For a closer look at that relationship, see our article on whether insulin resistance is the root risk driver for longevity.

That said, visceral fat is not the only significant risk factor for shortened lifespan. Low VO₂ max, smoking, poor sleep, and hypertension all carry substantial independent weight. However, visceral fat is one of the most modifiable — and one of the most underdiagnosed — which gives it practical priority in a longevity context. For broader context, the Longevity Testing and Trade-Offs hub covers how visceral fat fits alongside other key risk factors and what to prioritise first.

How to Identify Excess Visceral Fat

Visceral fat cannot be assessed reliably by appearance alone. A person with a relatively normal body weight can still carry clinically significant visceral fat — a pattern sometimes called “metabolically obese, normal weight.” This makes objective measurement important.

Waist Circumference

Waist circumference is the most accessible proxy for visceral fat. General thresholds that indicate elevated risk are above 94 cm (37 inches) for men and above 80 cm (31.5 inches) for women, though exact cut-offs vary by clinical guideline and ethnicity. Measuring at the level of the navel, in a relaxed standing position, provides a reasonable routine assessment.

Waist-to-Height Ratio

Waist-to-height ratio is increasingly preferred over waist circumference alone, as it adjusts for body size. A ratio above 0.5 is broadly used as an indicator of excess central adiposity. Evidence suggests it may predict cardiometabolic risk more accurately than BMI.

Imaging and Body Composition Scans

DEXA scans and MRI provide more precise measurements of visceral fat volume. These are more accurate than surface measurements, but they are also less accessible and more expensive. For most people, waist circumference combined with metabolic blood markers — such as fasting insulin, HbA1c, and triglycerides — provides a clinically useful picture without imaging.

Effective Strategies to Reduce Visceral Fat

Visceral fat is responsive to lifestyle intervention — in many cases more so than subcutaneous fat. The following approaches are supported by evidence:

Aerobic Exercise

Regular aerobic exercise — including brisk walking, cycling, running, and swimming — is one of the most consistently effective interventions for reducing visceral fat. High-intensity interval training (HIIT) appears particularly effective, with some studies showing greater reductions in visceral fat compared to moderate-intensity continuous exercise, even when total calorie expenditure is lower. Importantly, exercise can reduce visceral fat even in the absence of significant weight loss.

Dietary Changes

Diets lower in refined carbohydrates, added sugars, and ultra-processed foods are associated with reduced visceral fat accumulation. Higher intakes of dietary fibre, protein, and healthy unsaturated fats appear beneficial. No single dietary pattern has conclusively outperformed others specifically for visceral fat reduction — the most effective approach is one that is sustainable and reduces overall energy intake relative to expenditure.

Strength Training

Resistance training supports muscle mass and improves insulin sensitivity, both of which are relevant to visceral fat management. Combined with aerobic training, it appears to produce better outcomes than either approach alone.

Sleep and Stress Management

Poor sleep quality and chronic psychological stress both elevate cortisol, which promotes visceral fat accumulation. Addressing sleep duration and quality — and managing chronic stressors — is therefore not peripheral to visceral fat reduction but directly relevant to it.

What the Evidence Actually Shows

The relationship between visceral fat and disease risk is one of the better-established links in metabolic health research. Large prospective studies consistently show that central adiposity predicts cardiovascular events, type 2 diabetes onset, and all-cause mortality — often independently of BMI.

However, some important nuances are worth noting. Visceral fat is one risk factor among several. Reducing it meaningfully improves insulin sensitivity and lowers inflammatory markers such as CRP and interleukin-6, but it does not eliminate risk from other sources — poor cardiorespiratory fitness, elevated ApoB, smoking, and hypertension all require independent attention.

It is also worth noting that pursuing extremely low body fat in the name of longevity optimization carries its own risks. Very low body fat is associated with hormonal disruption, immune suppression, and reduced resilience to illness. The goal is not to eliminate body fat but to bring visceral fat specifically into a healthy range — a more achievable and clinically meaningful target.

Learn more in our complete guide to longevity.

References and Resources

Frequently Asked Questions

Conclusion

Visceral fat is one of the most clinically significant and modifiable risk factors in longevity medicine. Its metabolic activity — driving inflammation, insulin resistance, and cardiovascular dysfunction — makes it more consequential than overall body weight or BMI as a health indicator. Importantly, it also responds well to targeted lifestyle changes, often before overall body weight shifts noticeably.

That said, visceral fat is best understood as one important piece of a larger picture. Reducing it meaningfully improves metabolic health, but long-term wellbeing also depends on cardiorespiratory fitness, sleep quality, blood lipid control, and managing other established risk factors. The most effective approach focuses on sustainable habits rather than aggressive optimisation — which can introduce its own risks.